Condition
Tear Trough Eyelid Deformity
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (2)
P 3 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05742399Phase 1CompletedPrimary
Periocular Rejuvenation by Topical Hyaluronic Acid Nano Particles
NCT06318091Phase 1CompletedPrimary
Nanofat Versus Platelet Poor Plasma Gel for Infraorbital Rejuvenation
NCT06197789Phase 3CompletedPrimary
Safety and Efficacy Study of TPX-105 for Correction of Nasojugal Groove
NCT04486794Not ApplicableCompletedPrimary
Restylane® for the Treatment of Tear Trough Deformity
Showing all 4 trials